Shanghai Pharmaceuticals Holding Co., Ltd
45
19
19
22
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
2.2%
1 terminated/withdrawn out of 45 trials
95.7%
+9.1% vs industry average
4%
2 trials in Phase 3/4
0%
0 of 22 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (45)
A Clinical Study of B007 in the Treatment of Generalized Myasthenia Gravis.
Role: collaborator
A Phase II Clinical Study of LT3001 for Injection in the Treatment of Acute Ischemic Stroke
Role: lead
A Study to Efficacy and Safety of SPH4336 Monotherapy or in Combination With Cadonilimab in Patients With Advanced Solid Tumors.
Role: lead
A Clinical Study of T3011 in Subjects With Advanced Melanoma
Role: lead
Clinical Study of B001 Injection in Subjects With Neuromyelitis Optic Spectrum Disorder (NMOSD)
Role: lead
A Clinical Study of SPH9788 Tablets in Healthy Chinese Subjects.
Role: lead
A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD)
Role: collaborator
A Clinical Study of SPH7854 Granules in Healthy Subjects.
Role: lead
A Clinical Study of T3011 in Combination With PD-1/PD-L1 Inhibitors in Subjects With Advanced Solid Tumors
Role: lead
A Clinical Study of B007 in the Treatment of Pemphigus.
Role: collaborator
Efficacy and Safety of SPH4336 in Combination With Endocrine Therapy in Breast Cancer Patients With Brain Metastases.
Role: lead
A Study of B013 in Combination With Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer.
Role: collaborator
A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy.
Role: collaborator
SPH5030 Tablets in Subjects With Advanced Her2-positive Solid Tumors
Role: lead
Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke
Role: lead
A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy
Role: collaborator
A Clinical Study of TK216 in Patients With Relapsed or Refractory Ewing's Sarcoma
Role: lead
Safety and Efficacy of SPH4336 in Combination With Endocrine Therapy in the Treatment of Locally Advanced or Metastatic Breast Cancer
Role: lead
A Study of SPH3127 in the Treatment of Mild to Moderate Ulcerative Colitis
Role: lead
A Clinical Study of SPH7485 Tablets in the Treatment of Advanced Solid Tumors.
Role: lead